Xip Diagnostics

Xip Diagnostics is a medical technology company that developed a proprietary point-of-care diagnostic platform for rapid blood analysis. Originating from research at the University of California, Berkeley, the company's technology utilizes a low-cost, disposable microfluidic card to deliver lab-quality results for electrolytes and metabolites in minutes. The platform is designed for use in decentralized healthcare settings, improving patient monitoring and clinical decision-making for chronic and acute conditions. In 2021, the company was acquired by Werfen to bolster its acute care diagnostics business unit. The integration of Xip's technology enhances Werfen's portfolio of decentralized testing solutions.